Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
Muscle & Nerve
|
August 3, 2000
Cutaneous silent periods in patients with Fabry disease
N A Syed, F Sandbrink, C A Luciano, et al.
Experimental Hematology
|
February 1, 1994
Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol
L Xu, S K Stahl, H P Dave, et al.
Annals of Neurology
|
February 9, 2000
Profile of endothelial and leukocyte activation in Fabry patients
T DeGraba, S Azhar, F Dignat-George, et al.
AJNR. American Journal of Neuroradiology
|
April 27, 2019
<i>GJA1</i> Variants Cause Spastic Paraplegia Associated with Cerebral Hypomyelination
L Saint-Val, T Courtin, P Charles, et al.
Journal of Medical Genetics
|
June 7, 2005
Divergent phenotypes in Gaucher disease implicate the role of modifiers
O Goker-Alpan, K S Hruska, E Orvisky, et al.
Blood Cells, Molecules & Diseases
|
October 24, 2000
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease
G Altarescu, R Schiffmann, C C Parker, et al.
Stroke
|
July 7, 2001
Enhanced endothelium-dependent vasodilation in Fabry disease
G Altarescu, D F Moore, R Pursley, et al.
Neurology
|
March 19, 2008
Uniparental disomy of chromosome 1 causing concurrent Charcot-Marie-Tooth and Gaucher disease Type 3
W S Benko, K S Hruska, N Nagan, et al.
Experimental Hematology
|
July 2, 1999
Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease
T Takenaka, C S Hendrickson, D M Tworek, et al.
Clinical Genetics
|
April 25, 2006
Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease
W M Holleran, S G Ziegler, O Goker-Alpan, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
Muscle & Nerve
|
August 3, 2000
Cutaneous silent periods in patients with Fabry disease
N A Syed, F Sandbrink, C A Luciano, et al.
Experimental Hematology
|
February 1, 1994
Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol
L Xu, S K Stahl, H P Dave, et al.
Annals of Neurology
|
February 9, 2000
Profile of endothelial and leukocyte activation in Fabry patients
T DeGraba, S Azhar, F Dignat-George, et al.
AJNR. American Journal of Neuroradiology
|
April 27, 2019
<i>GJA1</i> Variants Cause Spastic Paraplegia Associated with Cerebral Hypomyelination
L Saint-Val, T Courtin, P Charles, et al.
Journal of Medical Genetics
|
June 7, 2005
Divergent phenotypes in Gaucher disease implicate the role of modifiers
O Goker-Alpan, K S Hruska, E Orvisky, et al.
Blood Cells, Molecules & Diseases
|
October 24, 2000
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease
G Altarescu, R Schiffmann, C C Parker, et al.
Stroke
|
July 7, 2001
Enhanced endothelium-dependent vasodilation in Fabry disease
G Altarescu, D F Moore, R Pursley, et al.
Neurology
|
March 19, 2008
Uniparental disomy of chromosome 1 causing concurrent Charcot-Marie-Tooth and Gaucher disease Type 3
W S Benko, K S Hruska, N Nagan, et al.
Experimental Hematology
|
July 2, 1999
Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease
T Takenaka, C S Hendrickson, D M Tworek, et al.
Clinical Genetics
|
April 25, 2006
Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease
W M Holleran, S G Ziegler, O Goker-Alpan, et al.
Page
of 9